Lv2
168 积分 2025-07-06 加入
Renal lipotoxicity in diabetic and obesity-associated kidney diseases: Molecular mechanisms and therapeutic targeting
2天前
已完结
Baseline and cumulative Chinese visceral adiposity index and diabetic kidney disease: A prospective cohort study
5天前
已完结
Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus
5天前
已完结
Peri-renal and renal sinus fat accumulation and diabetic kidney disease in type 2 diabetes: A Japanese cohort study
5天前
已完结
Sex-specific and BMI-specific associations between visceral fat and diabetic kidney disease in patients with diabetes: a large-scale multicentre prospective cohort study
5天前
已完结
Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit
5天前
已完结
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials
8天前
已完结
GLP-1 Receptor Agonists
8天前
已完结
Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real-World Observational Study
11天前
已完结
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial
11天前
已完结
皖公网安备34019202002308
